Prognostic impact of measurable residual disease in AML patients treated frontline with azacitidine and venetoclax: results from the French VENAURA registry

Leukemia · Published 2026-07-17 · DOI 10.1038/s41375-026-03024-y

Free full text

Authors (96)

Maël Heiblig, Zofia Gross, Amine Belhabri, Urbain Tauveron-Jalenques, Emmanuelle Tavernier, Gaspar Requena Aspas, Martin Carré, Adrien Contejean, Nadine Boullanger Fow Heng, Clémence Santana, Clément Rocher, Sylvain Lamure, Gian-Matteo Pica, Mauricette Michallet, Jérôme Cornillon, Mathieu Meunier, Natacha Mauz, Samy Chraibi, Ugo Thevenet, Arthur Dony, Grégoire Le Meur, Lucie Coster, Sylvie Tondeur, Emmanuel Beillard, Serge Carillo, Delphine Manzoni, Pascale Flandrin, Thomas Tassin, Sarah Huet, Adriana Plesa, French AURAML group, Guieze Romain, Aspas Requena Gaspar, Fayard Amandine, Ravinet Aurélie, Abdo Chrystelle, Abitayeh Rami, Balsat Marie, Baroudi Nboureddine, Barraco Fiorenza, Beillard Emmanuel, Belhabri Amine, Cacheux Victoria, Carre Martin, Chevalier Simon, Contejean Adrien, Cornillon Jérome, Dony Arthur, Doublet Charlotte, Ducastelle-Lepretre Sophie, Duprat Manon, Faure Anne Camille, Flandrin-Gresta Pascale, Fossard Gaelle, Gilis Lila, Girard Sandrine, Grange Béatrice, Hacini Maya, Hayette Sandrine, Huet Sarah, Jacob Marie Christine, Labussière-Wallet Hélène, Lachenal Florence, Lefebvre Christine, Legrand Clémentin, Lours Camille, Loron Sandrine, Manzoni Delphine, Mauz Natacha, Meunier Mathieu, Michallet Mauricette, Moluçon-Chabrot Cécile, Virelizier Emmenuelle-Nicolas, Noyel Pauline, Park Sophie, Parry Anne, Raskovalova Tatiana, Rigollet Lauren, Rocher Clément, Sujobert Pierre, Santana Clémence, Tardy Stéphanie, Tavernier Emmanuelle, Thiebaut Francoise, Thiebaut-Bertrand Anne, Tigaud Isabelle, Tondeur Sylvie, Gire Marion, Joassard Anaelle, Jaillard Lucie, Coster Lucie, Tauveron-Jalenques Urbain, Grimaud Yoann, Plesa Adriana, Lamure Sylvain, Fatrara Thomas

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year
2026

Citation

Heiblig, M., Gross, Z., Belhabri, A., et al. (2026). Prognostic impact of measurable residual disease in AML patients treated frontline with azacitidine and venetoclax: results from the French VENAURA registry. Leukemia. https://doi.org/10.1038/s41375-026-03024-y

Related articles